As required under Clause 7(3) of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of the certificate jointly issued by Company and Company Registrar and Share Transfer Agent - Kfin Technologies for year ended 31st March 2024.
The above information is a part of company’s filings submitted to BSE.